At A Glance
Pharma marketers can support more informed health journeys when patient and HCP messaging is relevant, privacy-forward, and optimized against meaningful outcomes. In this Ask the Expert conversation, Experian and DeepIntent discuss how health marketers can coordinate education, CTV, activation workflows, and measurement without entering private clinical decisions.Privacy-forward pharma media supports more informed healthcare journeys
Effective pharma marketing depends on reaching patients, caregivers, and healthcare professionals (HCPs) with useful information in appropriate, privacy-forward ways. The goal is to make relevant education easier to find, support more informed conversations, and help brands understand how media contributes across the health journey.
In this Ask the Expert session, Natalie Mancuso, SVP, Data Partnerships at DeepIntent, joins Sheila Wirick, who leads the health team at Experian, to discuss how to craft patient and HCP campaigns, privacy-safe activation workflows, connected TV (CTV), and measurement approaches built for pharma.
Why should your media plan start with understanding the patient and provider
The patient-and-provider journey should inform your media plan, as treatment decisions in pharma are increasingly informed, personal, and patient-driven. With more health information available than ever, patients are playing a more active role in understanding their options and participating in treatment conversations. As other industries become more customer-centric, pharma media planning needs to become more patient-centric.
“We’ve got patients who are more informed, more involved in their treatment decisions than ever. The accessibility of data and information and the ways we can consume it with just AI alone is so vast that if we’re not arming people with the right information in real time, we’re missing the boat.”
DeepIntentNatalie Mancuso, SVP, Data Partnerships
This means media should be aligned to where a patient or provider is in the decision journey and what they need at that moment. Early on, media may play an educational role by building awareness of a condition, symptom, or treatment category. Later, it may help support more specific questions, treatment consideration, access, affordability, or adherence.
The patient-provider conversation remains the key boundary. That exchange should stay private and clinically led. Media can play a valuable role before and after those moments by offering information that helps patients and providers feel more informed.
How can brands connect patient and HCP messaging responsibly?
It’s critical for agencies and brands to deliver relevant messaging to inform each stakeholder’s needs throughout the treatment journey, especially ahead of key clinical milestones. To execute this, brands must exercise privacy-forward activation, keeping patient and HCP identity, activation, and measurement paths separate, while using a common workflow layer to support the same brand goal.
Experian helps pharma marketers do this by acting as an independent, privacy-forward identity, data, and workflow layer. We bring together high-fidelity matching, governed onboarding, and non-clinical consumer context, so patient and HCP engagement can be activated more accurately across channels and connected to reporting.
The distinction is not only where each audience is reached. HCPs may be engaged in both professional and personal environments, but their needs are different from patients’. For example, an HCP may receive messaging about co-pay savings for eligible patients, while a patient may receive information about patient support programs. These are different messages for different audiences, but they ladder up to the same goal: informing both parties in a privacy-forward, relevant way.
Hear from Natalie Mancuso in our 2026 State of advertising report
In our 2026 State of advertising report, Natalie shares why identity serves as the connective infrastructure that links planning, activation, and measurement across connected TV (CTV), programmatic, commerce media, and walled garden environments.
What does privacy-forward activation look like in pharma?
Pharma brands often start with fragmented patient and HCP signals. Privacy-forward activation turns those inputs into usable audiences by first confirming that the data can be used, then translating identity in controlled environments that protect personally identifiable information through tokenization or other methodologies.
For DTC, that means building and matching audiences without relying on inferred health conditions from browsing behavior. For HCPs, it means connecting professional identity to verified sources in a way that supports activation and measurement. In a category shaped by HIPAA, state privacy laws, internal review, and consumer sensitivity, building privacy in from sourcing through activation is what makes responsible health media possible.
How can CTV play a more useful role in pharma?
CTV can play a more useful role in healthcare when it’s connected to a larger, privacy-forward plan and not treated as just an awareness channel.
DeepIntent connects CTV and digital exposure data using identity signals, such as National Provider Identifiers (NPIs), hashed email addresses, IP addresses, device IDs, and household signals, where permitted and reviewed. That identity layer helps support sequencing and suppression across streaming, endemic, mobile, and digital settings.
In practice, CTV can introduce targeted education or broad brand awareness, and later touchpoints can provide sequential information in the right channels. Instead of repeating the same message, brands can make pivots based on engagement and context.
“For us, it starts with identity and not panels. When we’re resolving CTV and digital exposures to the same person, we’re leveraging signals so that every touchpoint across streaming, endemic, and mobile is recognized as the same individual, not model lookalikes.”
DeepIntentNatalie Mancuso, SVP, Data Partnerships
For pharma, campaign performance should not be measured by reach alone. A stronger approach looks at whether sequenced engagement contributes to meaningful downstream signals, including:
- Prescription activity
- Provider engagement
- Referral patterns
- Patient compliance
- Adherence signals, where measurement is permitted
Why should messaging and reporting change in pharma?
Pharma campaigns are journeys with changing information needs. Reporting should guide the campaign optimization.
“If I’m launching into a market with a new class of drug, I’m asking what education needs to be put into the market – from both an HCP and a consumer standpoint – to build awareness?”
DeepIntentNatalie Mancuso, SVP, Data Partnerships
Clicks and website visits still have a place, but they can’t tell the full pharma story. DeepIntent processes data in real time, giving brands an up-to-date read on how media connects to campaign engagement. Campaign signals can help teams optimize audience logic, creative, channel mix, or sequencing during a live campaign.
Explore how privacy-safe pharma activation can make an impact
Experian brings marketing data and identity expertise for health marketing and DeepIntent adds pharma-specific activation experience. Together, we help brands connect patient and HCP strategies responsibly, with privacy built in from the start.
Watch the full video with our experts to hear Sheila Wirick and Natalie Mancuso discuss patient and HCP messaging, CTV, privacy-safe activation, and outcome measurement for pharma brands.
About our experts
Natalie Mancuso
SVP, Data Partnerships, DeepIntent
Natalie Mancuso is SVP, Data Partnerships at DeepIntent and a leader in health-focused AdTech and DSP strategy. With over 20 years of experience growing billion-dollar healthcare brands, she turns complex data into scalable, performance-driven solutions that keep marketers ahead of industry change.
Sheila Wirick
Director of Health Sales, Experian
Sheila Wirick is the Director of Health Sales at Experian with more than 20 years of experience in data and analytics. As Director of Health Sales at Experian Marketing Services, she collaborates with healthcare, pharmaceutical, and nonprofit organizations to apply data and insights that enhance customer retention, brand awareness, and acquisition. She is committed to helping organizations use data to deliver measurable results and meaningful impact.
FAQs
A pharma audience is activation-ready when patient or HCP inputs can be translated into usable audiences with the right accuracy, controls, interoperability, and destination readiness. For patient engagement, that may include privacy-safe cohort construction, caregiver logic, non-clinical enrichment and appropriate exclusion rules. For HCP engagement, it may include governed identity inputs such as NPI, specialty, practice location, professional address and other verified attributes where appropriate.
Pharma brands can sequence messages responsibly by giving each channel a clear role and using audience logic to maintain continuity. CTV and out-of-home can support awareness, social can reinforce the message, search can capture active research and point-of-care or rep-triggered channels can support decision moments. The workflow should preserve separation between patient and HCP identity strategies.
Pharma marketers should measure whether media connects to outcomes such as audience quality, prescription activity, qualified HCP engagement, verified delivery, referral patterns, therapy starts or adherence signals where permitted. These outcomes often depend on partner-enabled workflows, clean rooms, and aggregated outputs rather than direct end-to-end tracking.
Experian acts as an independent privacy-first identity, data, and workflow layer for pharma marketers. We help brands bring together identity, high-fidelity matching, governed onboarding, non-clinical consumer context, and partner interoperability so patient and HCP engagement can be activated more accurately across channels and connected more cleanly to partner-enabled measurement.
Latest posts
Tapad, a part of Experian, enters Asia Pacific to service regions’ rapidly expanding marketing technology sector
Featured storiesAs partnership deals mount, aggressive hiring underway for unified cross-screen technology leaders NEW YORK, July 19, 2016 /PRNewswire/ — Tapad, the leader in cross-device marketing technology and now a part of Experian, has announced plans for aggressive expansion in the Asia Pacific (APAC) region. This move capitalizes on Tapad’s exceptional performance for brands and marketing technology companies in North America and Europe. With it’s proprietary Tapad Device Graph™, the company will enable global, regional and local clients and partners to understand, monetize and measure marketing to users across screens. The Tapad Device Graph is recognized as the most accurate, scalable cross-screen solution in the market today. The decision to expand into APAC was based on increased demand from global, as well as local, brands and clients, many of which have a strong market presence throughout the region. In addition to expanding its roster of world-class data partners, plans include building a world-class team in Singapore. Over the next few months, Tapad APAC will also establish local entities in additional markets. To accelerate its ramp-up, Tapad APAC is actively recruiting in many areas, ranging from skilled and experienced solutions engineers to seasoned sales and marketing professionals. “Tapad is thrilled to be answering the call for cross-device excellence in APAC,” said Pierre Martensson, GM of Tapad APAC. “Our Device Graph is adding millions of devices daily and achieves unmatched levels of scale and accuracy while protecting consumer privacy. This meets a critical need in the region.” Tapad appointed Martensson as General Manager of Tapad APAC in May, kicking off expansion in the region. Martensson comes to Tapad with nearly a decade of operations experience throughout APAC, having transformed, developed and grown global organizations. To learn more about partnership and employment opportunities available with Tapad in APAC, visit www.experian.com/careers. Contact us today
Tapad, a part of Experian, and Conversion Logic provide a better understanding of customer journey
Featured storiesCombined technology gives marketers an enhanced view of the customer for improved planning, targeting and optimization NEW YORK, July 12, 2016/PR Newswire/ – Tapad, the leader in cross-device marketing technology and now a part of Experian, today announced a partnership with Conversion Logic, the martech industry’s most accurate unified marketing attribution provider. Conversion Logic will incorporate unified cross-screen data from Tapad’s Device Graph™ to identify related devices and media exposures to enhance reporting on the path to conversion. By connecting Conversion Logic’s proprietary Ensemble Method, which combines numerous state-of-the-art machine learning algorithms, tuned for each customer use-case for the most accurate results, with Tapad’s unified, cross-device technology, marketers will benefit from a highly scientific approach to assessing advertising effectiveness with full, comprehensive customer insights. Linking these technologies will increase marketers’ real-time ability to optimize brands’ marketing channel spend and creative at a more granular level. During the past six months, Tapad has rapidly grown its data business, doubling the number of companies integrating the Device Graph™ into their platforms and growing the annualized revenue run rate by 210%. Tapad’s highly scalable, cross-device data has been confirmed by Nielsen to be very precise. Tapad augments platforms’ and publishers’ tech stacks with additional scale and relevancy, granting advertisers amplified targeting and analysis options. The growth of the Device GraphTM has allowed Tapad to provide a growing network that benefits all partners with more efficient, effective consumer engagement. “Combining highly accurate data from Tapad with our own user ID technology and understanding how devices may be related at an individual level provides additional visibility into the path to conversion,” said Alison Lohse, COO and co-founder of Conversion Logic. “The more we know about the customer journey, the more effective, efficient and customized marketers can be with marketing efforts. With Tapad, we have achieved a unified customer view that helps us piece together the purchase journey while preserving proven accuracy.” “Conversion Logic’s Ensemble Method delivers singularly customized and precise results that are not just accurate, but actionable,” said Dave Fall, COO of Tapad. “The combination of powerful technology and a user-friendly interface, plus Tapad’s ability to only consider relevant and scalable components in the marketplace, creates a more concentrated and beneficial environment for both its partners and clients.” Contact us today
Madison Logic partners with Tapad, a part of Experian, to realize attribution across every channel for global B2B marketers
Featured storiesB2B marketers can now deliver the right message to the right user at the right time across devices and channels NEW YORK, NY–(Marketwired – Jun 1, 2016) – Madison Logic, one of the world’s fastest growing companies dedicated to solving the digital needs of B2B marketers, is partnering with Tapad, the leading provider of unified and now a part of Experian, cross-screen marketing technology solutions. Now business-to-business (B2B) marketers can power targeted advertising and content syndication programs across all channels, including smartphones, computers and tablets. The increasing shift in content consumption across mobile devices makes cross-device identification and attribution a top priority for B2B marketers. The Madison Logic and Tapad partnership gives B2B marketers unprecedented reach and scale with the ability to run always-on, cross-device, account-based marketing programs targeting decision makers who are actively researching similar products and services. “Screens are everywhere and so is the B2B buyer,” said Vin Turk, SVP of Audience Development for Madison Logic. “This partnership allows marketers to harness the power of Madison Logic’s intent data and combine it with Tapad’s cross-device solutions to connect with the most-likely-to-convert prospects with hyper-relevant content wherever and whenever they’re doing their research.” “Relevance is essential to the success of B2B marketers, particularly now, when breaking through the clutter is difficult,” said Dave Fall, COO of Tapad. “This partnership with Madison Logic allows marketers to leverage their existing customers while identifying and reaching new audiences with messaging tailored to every device.” For more information about Madison Logic’s account-based marketing platform, please visit https://www.madisonlogic.com/account-based-marketing/. For more information about Tapad’s cross-platform advertising solutions, please visit https://www.experian.com/marketing/consumer-sync. Contact us today